CorMedix (CRMD) EBT Margin (2015 - 2026)
CorMedix (CRMD) reported EBT Margin of 38.00% for Q2 2026, down 13.21 percentage points from 51.21% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) EBT Margin (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CorMedix's EBT Margin came in at 44.88%, up 2.34 percentage points year-over-year; for FY2025, it came in at 48.13%, up 92.58 percentage points from FY2024.
- EBT Margin has a five-year change of +11416.67 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -44.45% in FY2024, -46305.23% in FY2022 (-30875.76 pp) and -15429.47% in FY2021 (-4060.93 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q3 2024.
- Year over year, EBT Margin gained in three of the last four quarters, with an average year-over-year change of +467.23 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2022 (a gain of 33286.33 percentage points); the low point was Q1 2022 (a drop of 83813.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | CorMedix | 615.90 Mn | -36.62 Mn | 77.13 Mn | 38.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00% |
| Dec 31, 2025 | 43.89% |
| Sep 30, 2025 | 50.42% |
| Jun 30, 2025 | 51.21% |
| Mar 31, 2025 | 52.82% |
| Dec 31, 2024 | 43.14% |
| Sep 30, 2024 | -24.24% |
| Jun 30, 2024 | -1,755.51% |
| Dec 31, 2022 | -27,637.70% |
| Sep 30, 2022 | -100,538.67% |
| Jun 30, 2022 | -38,537.88% |
| Mar 31, 2022 | -91,985.18% |
| Dec 31, 2021 | -13,814.54% |
| Sep 30, 2021 | -22,498.86% |
| Jun 30, 2021 | -71,824.21% |
| Mar 31, 2021 | -8,171.25% |
| Dec 31, 2020 | -10,925.34% |
| Sep 30, 2020 | -7,096.05% |
| Jun 30, 2020 | -54,441.52% |
| Mar 31, 2020 | -7,500.40% |
API Access
CorMedix EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();